InvestorsHub Logo
Followers 833
Posts 119848
Boards Moderated 17
Alias Born 09/05/2002

Re: vinmantoo post# 2297

Monday, 08/08/2022 5:23:27 PM

Monday, August 08, 2022 5:23:27 PM

Post# of 3009

Does this mean ENTA is thinking of going it alone down the line with perhaps with the RSV or HBV drugs?

ENTA might be able to commercialize without a partner in RSV, but I doubt they would attempt to do so in HBV, where a large proportion of the addressable market is ex-US.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News